Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.0K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

445
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
445
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

49
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
49
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

931
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
931
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

251
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
251

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structured reasoning failures compromise LLM interpretation of clinical oncology notes.

NPJ digital medicine·2026
Same author

Fine-Tuning, Retrieval-Augmented Generation, and Hybrid Large Language Models for Postoperative Decision Support: A Comparative Analysis.

Journal of medical Internet research·2026
Same author

Federated target trial emulation for time-to-event outcomes via POLARIS: Pooled-equivalent One-shot Likelihood Aggregation for Real-world Inference in Survival.

Research square·2026
Same author

Optimizing Retrieval-Augmented Generation (RAG) in clinical medicine: methods and performance evaluation.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

From "negative" trial to positive clinical impact: mitigating eligibility criteria-induced temporal selection bias in emulated clinical trials.

npj health systems·2026
Same author

AI-Generated Avatar Videos for Postoperative Patient Education Among Health Care Workers: Pilot Randomized Controlled Trial.

JMIR perioperative medicine·2026

Related Experiment Video

Updated: Mar 3, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K

Modulated evaluation metrics for drug-based ontologies.

Muhammad Amith1, Cui Tao2

  • 1School of Biomedical Informatics, University of Texas Health Science Center, Fannin Street, Houston, Texas, USA.

Journal of Biomedical Semantics
|April 26, 2017
PubMed
Summary
This summary is machine-generated.

A new semiotic-inspired evaluation method improves the quality assessment of drug ontologies. Tailoring quality metrics enhances precision and accuracy for biomedical knowledgebases.

Keywords:
Drug ontologiesKnowledgebasesMetricsOntologyOntology evaluationQuality assessmentSemiotics

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

Related Experiment Videos

Last Updated: Mar 3, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

Area of Science:

  • Biomedical Informatics
  • Ontology Engineering
  • Drug Discovery

Background:

  • Limited research exists for ontology evaluation, hindering the widespread use of biomedical datasets and knowledgebases.
  • Effective quality control for ontology content and structure is crucial for reliable data.
  • This study focuses on drug-related ontologies within the National Center for Biomedical Ontology BioPortal.

Purpose of the Study:

  • To introduce and evaluate a semiotic-inspired approach for assessing drug-related ontologies.
  • To demonstrate the effectiveness of tailoring quality metrics using semiotic features.
  • To improve the accuracy and meaningfulness of ontology evaluations.

Main Methods:

  • Developed a semiotic-based evaluation framework specifically for drug ontologies.
  • Adjusted existing quality metrics by incorporating semiotic features relevant to drug information.
  • Compared ontology quality scores before and after the tailored semiotic evaluation.

Main Results:

  • The tailored semiotic evaluation provided a more precise measurement of ontology quality.
  • The adjusted quality scores showed a closer distribution, indicating improved assessment accuracy.
  • The framework effectively enhanced the evaluation of drug-based ontologies.

Conclusions:

  • A tailored semiotic evaluation significantly improves the assessment of drug-based ontologies.
  • Semiotics offers a valuable and potentially useful approach for enhancing ontology evaluation.
  • This method contributes to better quality control for biomedical knowledge resources.